Netcompany developed the National Biomedical Research Registry on behalf of the Hellenic National Organization for Medicines (EOF) and delivered it to IDYKA. This project creates a unified, reliable platform for recording and monitoring all types of biomedical research conducted in Greece. It is a project of strategic importance, aimed at enhancing the country’s position within the international clinical research ecosystem.
According to the relevant press release, the project aims to fill the gap by serving as a single source of information that will reliably compile and present data on how many and which studies are being conducted in Greece, where delays in procedures occur, and what the overall impact is on the healthcare system and the economy. This will enhance transparency, international credibility, and the country’s competitiveness.
With the upcoming implementation of the system, the entire research process will be digitized: application submission, contract signing, monitoring of trial conduct at the country’s research centers, and financial settlement, providing a comprehensive overview of activity in the country.
The system is interoperable with the European Union Clinical Trials Information System (CTIS), strengthening cross-border collaboration in research. In this way, Greece becomes more attractive for investment, research, and innovation, enabling more patients to access new treatments.
At the core of the project is Netcompany’s AMPLIO platform, a comprehensive solution that supports the design and execution of digital processes and workflows.
“This is a project with immediate benefits for patients, hospitals, researchers, and our country. In combination with other, very important projects we are implementing, such as upgrading the digital readiness of the country’s largest hospitals, we are creating the conditions for innovation in healthcare to reach its greatest value more quickly: the people,” said Christos Kontellis, Country Managing Partner at Netcompany SEE.